Holdings of the Fund as of 3/31/2025
Total Number of Holdings (excluding cash): 50
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
18,970 |
$1,156,980.30 |
7.64% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,854 |
$1,136,667.36 |
7.50% |
AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,411 |
$1,133,712.72 |
7.48% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
12,260 |
$1,100,457.60 |
7.26% |
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
42,793 |
$1,084,374.62 |
7.16% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,836 |
$572,005.80 |
3.78% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,381 |
$556,681.65 |
3.67% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
4,947 |
$554,311.35 |
3.66% |
Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,025 |
$550,781.00 |
3.64% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,767 |
$544,713.09 |
3.60% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
61,269 |
$533,652.99 |
3.52% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
809 |
$513,092.07 |
3.39% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
614 |
$507,108.74 |
3.35% |
Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,940 |
$489,151.00 |
3.23% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
27,431 |
$408,447.59 |
2.70% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,963 |
$295,470.76 |
1.95% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
7,725 |
$285,207.00 |
1.88% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
859 |
$261,728.71 |
1.73% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
23,129 |
$242,854.50 |
1.60% |
Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
2,959 |
$234,767.06 |
1.55% |
Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,591 |
$229,141.71 |
1.51% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,788 |
$197,752.80 |
1.31% |
BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
2,780 |
$196,518.20 |
1.30% |
Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,046 |
$166,618.92 |
1.10% |
Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,287 |
$147,001.14 |
0.97% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
5,138 |
$144,069.52 |
0.95% |
Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
15,042 |
$126,051.96 |
0.83% |
Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,385 |
$119,068.45 |
0.79% |
Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,636 |
$112,423.00 |
0.74% |
TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,591 |
$102,163.13 |
0.67% |
ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,757 |
$94,378.88 |
0.62% |
Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
316 |
$85,326.32 |
0.56% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
602 |
$82,937.54 |
0.55% |
Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,832 |
$78,043.20 |
0.52% |
Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
435 |
$78,430.50 |
0.52% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
162 |
$78,540.84 |
0.52% |
Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
228 |
$75,520.44 |
0.50% |
Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
956 |
$72,933.24 |
0.48% |
Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Biotechnology |
611 |
$71,260.93 |
0.47% |
Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
807 |
$71,427.57 |
0.47% |
Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,644 |
$71,168.76 |
0.47% |
PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
1,411 |
$71,904.56 |
0.47% |
Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,520 |
$67,822.40 |
0.45% |
ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,978 |
$66,074.58 |
0.44% |
Veracyte, Inc. |
VCYT |
92337F107 |
Biotechnology |
2,243 |
$66,504.95 |
0.44% |
Scholar Rock Holding Corporation |
SRRK |
80706P103 |
Biotechnology |
2,008 |
$64,557.20 |
0.43% |
Akero Therapeutics, Inc. |
AKRO |
00973Y108 |
Biotechnology |
1,587 |
$64,241.76 |
0.42% |
Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,061 |
$64,243.55 |
0.42% |
SpringWorks Therapeutics, Inc. |
SWTX |
85205L107 |
Biotechnology |
1,350 |
$59,575.50 |
0.39% |
Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
730 |
$46,588.60 |
0.31% |
US Dollar |
$USD |
|
Other |
16,420 |
$16,420.04 |
0.11% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|